| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/28/2006 | WO2006030323A3 Compounds that inhibit replication of human immunodeficiency virus |
| 12/28/2006 | WO2006003518A3 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 12/28/2006 | US20060293507 Crystallization of IGF-1 |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293344 Viricide against herpes virus; a pyrazolo[1,5- alpha]pyridinyl compounds; chemical synthesis |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293307 Oxazolidinone derivatives as antimicrobials |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | US20060293302 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions |
| 12/28/2006 | US20060293285 Aryl Phosphate Derivatives of d4T |
| 12/28/2006 | US20060293284 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 12/28/2006 | US20060293263 Preparation for preventing contact of pathogenic matter with living organism |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection |
| 12/28/2006 | US20060292655 2-O sulfatase compositions and methods of analyzing therewith |
| 12/28/2006 | US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases |
| 12/28/2006 | US20060292644 Novel tumor-associated marker |
| 12/28/2006 | US20060292204 5,7,3',4'-Tetrahydroxy-5'-C-geranylflavanone (isonymphaeol-B), isolated from an Okinawa propolis; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement |
| 12/28/2006 | US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 12/28/2006 | US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 12/28/2006 | US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 12/28/2006 | US20060292160 Specifically reacts with HIV-infected cells and induces apoptosis to the infected cells to lead the cells to destruction; immunoglobulins |
| 12/28/2006 | US20060292133 Use of lactobacillus salivarius |
| 12/28/2006 | US20060292130 2-O sulfatase nucleic acid compositions |
| 12/28/2006 | US20060292118 Hollow nanoparticles of protein and drug using the same |
| 12/28/2006 | US20060292116 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 12/28/2006 | US20060292112 Dendrimer-photosensitizer complexes for medical applications |
| 12/28/2006 | DE10356409B4 Neues Arzneimittel Oxachelin und Derivate New drug Oxachelin and derivatives |
| 12/28/2006 | DE102004032888B4 Rekombinante ScV-Partikel, ihre kodierenden Nukleinsäuren und ihre Verwendungen Recombinant SCV particle, its encoding nucleic acids and their uses |
| 12/28/2006 | CA2836319A1 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 12/28/2006 | CA2613297A1 Composition for treating skin lesions |
| 12/28/2006 | CA2612945A1 Anti-aids agent |
| 12/28/2006 | CA2612900A1 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 12/28/2006 | CA2612403A1 Antiviral compounds and methods |
| 12/28/2006 | CA2611151A1 Use of sanglifehrin in hcv |
| 12/28/2006 | CA2610828A1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 12/28/2006 | CA2610812A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2610617A1 The preparation and use of protease inhibitors |
| 12/28/2006 | CA2609562A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 12/28/2006 | CA2608278A1 Immunogenic compositions for chlamydia trachomatis |
| 12/28/2006 | CA2587189A1 Methods and compositions involving mirna and mirna inhibitor molecules |
| 12/27/2006 | EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736466A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 12/27/2006 | EP1734976A1 Extracts of scutellaria for the treatment of sars |
| 12/27/2006 | EP1734966A2 Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 12/27/2006 | EP1734950A2 Treating a viral disorder |
| 12/27/2006 | EP1734946A2 Method of using punicic acid to enhance immune response and prevent metabolic disorders |
| 12/27/2006 | EP1539964B1 Collectin-complement activating protein chimeras |
| 12/27/2006 | EP1534717B1 Beta-lactamase inhibitor prodrug |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1418180B1 Chimeric chains that code for proteins that induce effects directed against viruses |
| 12/27/2006 | EP1404704B1 Bridged bicyclic serine protease inhibitors |
| 12/27/2006 | EP1358209B1 Crystallization of igf-1 |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection |
| 12/27/2006 | EP1185618B1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 12/27/2006 | EP1084252B1 Nucleic acid vaccines for prevention of flavivirus infection |
| 12/27/2006 | EP1028742B1 Apo b, annexin v and tubulin : medical, diagnostic and purification uses for hcv |
| 12/27/2006 | EP1021547B1 Papilloma virus capsomere vaccine formulations and methods of use |
| 12/27/2006 | EP1003875B1 Group a streptococcal vaccines |
| 12/27/2006 | EP0918458B1 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 12/27/2006 | EP0817797B1 Glycopeptide antibiotic derivatives |
| 12/27/2006 | CN1886511A Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 12/27/2006 | CN1886506A Protein expressed in nk cell |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886408A Polymorphous forms of rifaximin, processes for production and use in medicinal preparations |
| 12/27/2006 | CN1886147A Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 12/27/2006 | CN1884552A Recombinant Ag85B-Rv3425 bacillus Calmette-Guerin vaccine |
| 12/27/2006 | CN1884497A Reovirus vaccine and its preparing method |
| 12/27/2006 | CN1884302A Staphylococcus aureus fusion protein of fibronectin and bindin, its preparation method and uses |
| 12/27/2006 | CN1884299A Staphylococcus aureus surface protein fusion protein, its preparation method and uses |
| 12/27/2006 | CN1884271A Zedoary cyclo-diolefine and its derivatives preparation method and use |
| 12/27/2006 | CN1883705A Application of cysteamine and derivative thereof in preparation of medicament for improving bird flu antibody potency |
| 12/27/2006 | CN1883704A Hepatitis A-hepatitis E combined vaccine and preparation method thereof |
| 12/27/2006 | CN1883679A Medicine for treating pulmonary tuberculosis |
| 12/27/2006 | CN1883677A Powder for treating beriberi and preparation method thereof |
| 12/27/2006 | CN1883651A Chinese medicinal composition for treating wind-heat cold and preparation method thereof |
| 12/27/2006 | CN1883647A Anti-herpes, anti-HIV medicine and preparation method thereof |
| 12/27/2006 | CN1883622A Externally applied medicine for treating dermatosis and preparation method thereof |
| 12/27/2006 | CN1883620A Gel agent for treating superficial mycotic infection and method for preparing same |
| 12/27/2006 | CN1883610A Chinese animal medicine for treating birds viral disease and method for preparing same |
| 12/27/2006 | CN1883604A Quality control method of compound preparation with red sage root and cape jasmine for treating acute and chronic hepatitis |
| 12/27/2006 | CN1883599A Chinese medicinal composition for treating women's episioitis or colpitis and method for preparing same |
| 12/27/2006 | CN1883596A Chinese medicinal composition for treating lymphnode tuberculosis |
| 12/27/2006 | CN1883590A Method for preparing ganoderma spore oil |
| 12/27/2006 | CN1883582A Pharmaceutical composition for treating liver disease and method for preparing same |
| 12/27/2006 | CN1883579A Method for treating jaundice hepatitis |
| 12/27/2006 | CN1883568A Chinese medicinal ointment for treating beriberi |
| 12/27/2006 | CN1883556A A nano preparation of 'Kang'ai' injection and method for preparing same |
| 12/27/2006 | CN1883555A A medicine for treating beriberi |
| 12/27/2006 | CN1883550A A medicine for treating dermatosis |
| 12/27/2006 | CN1883546A Medicine for treating myocarditis |
| 12/27/2006 | CN1883528A Chinese medicine extracts for improving immunity and treating human and animal influenza |
| 12/27/2006 | CN1883522A An anti-tumor antibiotic and anti-inflammation pharmaceutical composition and preparation method thereof |
| 12/27/2006 | CN1883520A Hypericum perforatum L. phenolic acid and injection thereof preparation method |
| 12/27/2006 | CN1883517A Preparation of fungi extract and application thereof in resisting HIV |
| 12/27/2006 | CN1883511A Inclusion compound of ants supercritical extracts and preparation process thereof |